Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AKTX
AKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AKTX News
SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm
2d ago
NASDAQ.COM
U.S. Stocks Reach Record Highs as Investor Optimism Grows
3d ago
stocktwits
Akari Therapeutics Shows Promising Cancer Treatment Progress
3d ago
stocktwits
Akari Therapeutics Showcases Promising ASCO Data on AKTX-101
3d ago
Newsfilter
Biotech Stocks Surge with Akari Leading the Rally
5d ago
NASDAQ.COM
Biotech Sector Attracts Investor Attention Amid Innovation
May 22 2026
Globenewswire
Akari Therapeutics Shares Surge Over 100% on Breakthrough Data
May 22 2026
NASDAQ.COM
Akari's Cancer Therapy Data Sparks 120% Stock Surge
May 22 2026
seekingalpha
Multiple Companies Experience Significant Stock Price Gains
May 22 2026
NASDAQ.COM
Akari Therapeutics Begins Human Trials for AKTX-101
May 22 2026
stocktwits
Akari Therapeutics' Novel ADC Shows Promise Against KRAS-Driven Cancers
May 21 2026
Newsfilter
Akari Therapeutics Prices $5.5M Private Placement Financing
May 21 2026
seekingalpha
Akari Therapeutics Raises $5.5 Million in Private Placement Financing
May 21 2026
Newsfilter
Akari Secures European Patent to Strengthen IP Position
May 12 2026
Newsfilter
Akari Secures Australian Patent, Strengthening ADC Platform
Apr 27 2026
Newsfilter
Akari Therapeutics Presents Positive Preclinical Data for AKTX-101
Apr 21 2026
NASDAQ.COM
Show More News
